DrugPatentWatch Database Preview

Ceftaroline fosamil - Generic Drug Details

  Purchase this report

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for ceftaroline fosamil and what is the scope of ceftaroline fosamil freedom to operate?

Ceftaroline fosamil is the generic ingredient in one branded drug marketed by Allergan Sales Llc and is included in one NDA. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ceftaroline fosamil has sixty-six patent family members in thirty-two countries.

There are two drug master file entries for ceftaroline fosamil. One supplier is listed for this compound.

Summary for ceftaroline fosamil

International Patents:	66
US Patents:	5
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	2
Suppliers / Packagers:	1
Bulk Api Vendors:	11
Clinical Trials:	36
Patent Applications:	16
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ceftaroline fosamil
DailyMed Link:	ceftaroline fosamil at DailyMed

Pharmacology for ceftaroline fosamil

Ingredient-type	Cephalosporins
Drug Class	Cephalosporin Antibacterial

Synonyms for ceftaroline fosamil

(6R,7R)-7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

(6R,7R)-7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate acetate--water (1/1

(6R,7R)-7-[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

229016-73-3

400827-46-5

595568-96-0

7P6FQA5D21

866021-48-9

AK322190

AKOS027326632

ceftarolina fosamilo

Ceftaroline

Ceftaroline acetate

Ceftaroline fosamil (USAN/INN)

Ceftaroline fosamil [USAN:INN:BAN]

Ceftaroline fosamil acetate

Ceftaroline fosamil acetate anhydrous

Ceftaroline fosamil acetate monohydrate

Ceftaroline Fosamil Inner salt

Ceftaroline inner salt

ceftarolinum fosamilum

CHEBI:70714

CHEBI:70718

CHEMBL3544973

CHEMBL501122

CS-2823

D08884

DB06590

DTXSID50193133

DTXSID60177444

EZ9W6O5S09

HY-14737

PPI 0903

PPI-0903

Pyridinium, 4-(2-(((6R,7R)-2-carboxy-7-(((2Z)-(ethoxyimino)(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetyl)amino)-8-oxo-5-thia-1- azabicyclo(4.2.0)oct-2-en-3-yl)thio)-4-thiazolyl)-1-methyl-, acetate

Pyridinium, 4-(2-(((6R,7R)-2-carboxy-7-(((2Z)-2-(ethoxyimino)-1-oxo-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)ethyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)thio)-4-thiazolyl)-1-methyl-, inner salt

SCHEMBL1464037

TAK 599

TAK-599

Teflaro

Teflaro (TN)

UNII-7P6FQA5D21

UNII-EZ9W6O5S09

Zinforo

US Patents and Regulatory Information for ceftaroline fosamil

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allergan Sales Llc	TEFLARO	ceftaroline fosamil	POWDER;IV (INFUSION)	200327-002	Oct 29, 2010		RX	Yes	Yes
Allergan Sales Llc	TEFLARO	ceftaroline fosamil	POWDER;IV (INFUSION)	200327-001	Oct 29, 2010		RX	Yes	No			Y
Allergan Sales Llc	TEFLARO	ceftaroline fosamil	POWDER;IV (INFUSION)	200327-001	Oct 29, 2010		RX	Yes	No			Y
Allergan Sales Llc	TEFLARO	ceftaroline fosamil	POWDER;IV (INFUSION)	200327-001	Oct 29, 2010		RX	Yes	No			Y

  Purchase this report

or, see our see our flat-rate plans

  Purchase this report

or, see our see our flat-rate plans

International Patents for ceftaroline fosamil

Country	Document Number	Estimated Expiration
Germany	69840796
Japan	3467418
Honduras	2012000585
South Korea	100826487

Supplementary Protection Certificates for ceftaroline fosamil

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0008	France		PRODUCT NAME: CEFTAROLINE FOSAMIL, SES ESTERS OU SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/12/785/001 20120823
134	Luxembourg		PRODUCT NAME: CEFTAROLINE FOSAMIL ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (ZINFORO)
2013 00003	Denmark
13/001	Ireland		PRODUCT NAME: CEFTAROLINE FOSAMIL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/12/785/001 20120823